A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
about
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesSurgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastasesAdvances in diagnosis and treatment of metastatic cervical cancerNational consensus in China on diagnosis and treatment of patients with advanced breast cancerBreast cancer brain metastases: the last frontierThe role of magnetic resonance imaging in the management of brain metastases: diagnosis to prognosisManagement of solitary and multiple brain metastases from breast cancerAdvances in treatment of brain metastases from primary non-small cell lung cancerThe vascular basement membrane as "soil" in brain metastasisTargeted Therapies for Brain Metastases from Breast CancerMelanoma Brain Metastasis: Mechanisms, Models, and MedicineBRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapyIs upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and olderBreast Cancer Brain Metastases: Clonal Evolution in Clinical Context.Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times.Early Diagnosis of Brain Metastases Using a Biofluids-Metabolomics Approach in Mice.Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.Prognostic indices for brain metastases--usefulness and challengesPrognostic scores in brain metastases from breast cancer.Presentation and outcome in cancer patients with extensive spread to the brain.Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional studyStereotactic radiosurgery in the management of brain metastases from primary thyroid cancers.Treatment of single or multiple brain metastases by hypofractionated stereotactic radiotherapy using helical tomotherapy.A minimally invasive treatment option for large metastatic brain tumors: long-term results of two-session Gamma Knife stereotactic radiosurgery.Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.Establishment of a Disease-Specific Graded Prognostic Assessment for Hepatocellular Carcinoma Patients with Spinal Metastasis.Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment.Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes.Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of deathThe role of whole brain radiation therapy in the management of melanoma brain metastasesThe impact of tumour histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients.Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies.A nomogram for individualized estimation of survival among patients with brain metastasisProspective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastasesPrescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases.Ventriculoperitoneal shunting versus endoscopic third ventriculostomy in the treatment of patients with hydrocephalus related to metastasis.Treatment patterns, clinical outcomes and health care costs associated with HER2-positive breast cancer with central nervous system metastases: a French multicentre observational study
P2860
Q24198129-D401399C-C1C4-48CE-9BDA-09FC05F8E090Q24235688-D121C94D-5044-48E8-831B-86DF1DDDC2D1Q26750408-D609BEBF-DC34-4C81-B898-016EEF76E731Q26775621-AD3E2F44-E78E-40D0-BBD4-3F33637FCBD3Q26775663-84E28D20-CB18-40A7-845A-53A1E7C384C1Q26825055-F7AF8F5D-EC03-48D6-A4D6-F4A1BCB0BAA2Q26865562-927F4234-72DB-45EA-A83A-2F3A58DCA406Q27022452-7375C687-D5BD-4179-B2DD-2411D0F9C7EDQ27348725-B2C9ABE2-1714-444C-959D-FF69A2BF7EA0Q28068154-7EABC9F0-B782-4836-AC8A-4966F35B4B31Q28069421-8EB0C4A0-6332-4639-8B45-A697ADF3C785Q28076667-8A6D06AA-4FC8-49F7-94A3-02AFE8A5CFA7Q28396583-A6BF1223-C337-4D54-AC55-CEFD5DD942A1Q30238959-BB4507D8-40FF-486A-B93C-D982F88A3BAFQ30587443-977D11E2-37AE-476B-ADDF-3220378076B7Q30830687-29F889A3-B991-4618-B951-41F86E85E8AFQ31141368-769CBC00-4909-40AA-AA35-AEFD4827E705Q33414874-0D59E489-066A-4827-97BF-979C9A2DAD19Q33427624-5A3D3F4B-B7D4-47CD-A484-2A246E4DACB9Q33517956-661984CD-045D-45DA-AE88-76875D42A37DQ33532301-379296E4-D362-4279-A6A7-A529331EB9E2Q33550864-FB03ADE9-DE1D-460D-984D-8C2406C00597Q33580813-AD09A924-B581-4F9E-B873-EF640D9932C2Q33775427-F1BDC638-5CF6-4F68-AE82-0A400D6738E5Q33834894-D706DD59-2BC5-41C2-AFD6-C1BD681B0145Q33853201-6D409C23-A5B0-480C-BA34-9FC71CB12F26Q33874796-8229A2C0-B576-43C7-A516-2EDBE34E8E0FQ33953465-0DEB86E0-4F46-47CF-A030-2D723FD45A08Q33962077-BA93AAAE-A267-47E5-860B-C023CE12A331Q34019690-DEF508AD-674E-48FB-BA7F-00E54CE617A5Q34022312-0A355821-9AE0-46D8-8D35-216601A297A4Q34042684-7FA9932B-01CB-4921-9C51-06F14D7712BCQ34054681-0BD9532A-DDD6-4768-9724-41EC2024C852Q34123319-C5053D62-DE7D-4826-B8FB-5B816E6A22F3Q34242516-7A18C3E7-9E97-412B-AA70-E954142CF584Q34250819-DC72281A-6C66-4267-B304-4E413B23502EQ34332364-F6D4135D-C44F-4068-9E65-A7CBAD2BBF6AQ34333386-3B71D08A-BAAA-4E94-996C-45C85083872BQ34444293-04F3E478-AB3A-45D8-ACE8-D3C31275E928Q34493571-DF840AFA-0FD5-4886-B88C-F80133BACA57
P2860
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
A new prognostic index and com ...... patients in the RTOG database.
@ast
A new prognostic index and com ...... patients in the RTOG database.
@en
A new prognostic index and com ...... patients in the RTOG database.
@nl
type
label
A new prognostic index and com ...... patients in the RTOG database.
@ast
A new prognostic index and com ...... patients in the RTOG database.
@en
A new prognostic index and com ...... patients in the RTOG database.
@nl
prefLabel
A new prognostic index and com ...... patients in the RTOG database.
@ast
A new prognostic index and com ...... patients in the RTOG database.
@en
A new prognostic index and com ...... patients in the RTOG database.
@nl
P2093
P1476
A new prognostic index and com ...... patients in the RTOG database
@en
P2093
Brian Berkey
Laurie E Gaspar
Paul W Sperduto
Walter Curran
P304
P356
10.1016/J.IJROBP.2007.06.074
P407
P50
P577
2007-10-10T00:00:00Z